Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novartis AG

116.43
+0.83000.72%
Volume:159.36K
Turnover:18.49M
Market Cap:229.96B
PE:19.83
High:116.57
Open:115.50
Low:115.44
Close:115.57
Loading ...

PTC Therapeutics Inks Licensing Pact With Novartis Worth Up To ~$3 Billion For Huntington's Program

Benzinga
·
03 Dec 2024

PTC Therapeutics Strikes Up to $2.9 Billion Licensing Deal With Novartis for Huntington's Disease Drug Candidate

MT Newswires
·
02 Dec 2024

Sector Update: Health Care Stocks Mixed Pre-Bell Monday

MT Newswires Live
·
02 Dec 2024

Olema Partners With Novartis for Clinical Trial of Potential Breast Cancer Drug, Launches $250 Million Stock, Warrant Placement

MT Newswires Live
·
02 Dec 2024

PTC Therapeutics Signs Exclusive Global License Deal With Novartis Unit for PTC518 Huntington's Disease Program; Shares Rise Premarket

MT Newswires Live
·
02 Dec 2024

The Zacks Analyst Blog Highlights Roche, Poseida Therapeutics, Merck, AstraZeneca and Novartis

Zacks
·
02 Dec 2024

Novartis AG (NVS): A Bull Case Theory

Insider Monkey
·
01 Dec 2024

Why Novartis AG (NVS) Is One of the Most Profitable Pharmaceutical Stocks Right Now?

Insider Monkey
·
01 Dec 2024

Pharma Stock Roundup: RHHBY to Buy PSTX, MRK, AZN See Pipeline Success

Zacks
·
30 Nov 2024

Novartis AG Rises Thursday, Outperforms Market

Dow Jones
·
29 Nov 2024

EC Approves NVS' Kisqali for a Broad Population in Early Breast Cancer

Zacks
·
29 Nov 2024

The best Vanguard ASX ETF to invest $2,000 in right now

MotleyFool
·
28 Nov 2024

Novartis Receives European Commission Approval for Adjuvant Early Breast Cancer Treatment

MT Newswires Live
·
27 Nov 2024

FDA Begins Review of Alnylam's sNDA for Expanded Amvuttra Use

Zacks
·
26 Nov 2024

Novartis Boosts Growth Outlook with Strong Pipeline

TIPRANKS
·
25 Nov 2024

MNOV: Monetary Damages Due Following Sanofi/Novartis Patent Dispute Settlement…

Zacks Small Cap Research
·
25 Nov 2024